Dose to cardiac substructures predicts survival in non-small cell lung cancer chemo-radiotherapy

被引:2
|
作者
Thor, M. [1 ]
Hotca, A. [2 ]
Jackson, A. [1 ]
Yorke, E. [1 ]
Rimner, A. [2 ]
Deasy, J. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Med Phys, 1275 York Ave, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Radiat Oncol, 1275 York Ave, New York, NY 10021 USA
关键词
D O I
10.1016/S0167-8140(18)30422-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
SP-0112
引用
收藏
页码:S58 / S59
页数:2
相关论文
共 50 条
  • [41] Chemo-radiotherapy before surgery in stage III non-small-cell lung cancer
    Bonnette, P.
    [J]. REVUE DES MALADIES RESPIRATOIRES, 2013, 30 (02) : 105 - 114
  • [42] Chemo-radiotherapy in stage III non-small cell lung carcinoma: does the choice of chemotherapy matter?
    Ang, J. K. H.
    Tan, S. H.
    Tan, D. S. W.
    Kim, S. W.
    Fong, K. W.
    Ang, M. K.
    Lim, W. T.
    Tan, E. H.
    Kanesvaran, R.
    Toh, C. K.
    Ng, Q. S.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S604 - S604
  • [43] Gross tumour volume predicts survival and correlates with pre-treatment serum albumin concentration in patients with stage III non-small cell lung cancer treated with chemo-radiotherapy
    Killean, Angus
    Fenner, Florence
    Stares, Mark
    Evans, Tamasin
    Maclennan, Kirsty
    Tufail, Aisha
    Campbell, Sorcha
    Harrow, Stephen
    McLaren, Duncan
    Phillips, Iain
    [J]. LUNG CANCER, 2022, 165 : S56 - S57
  • [44] SBRT Dose and Survival in Non-Small Cell Lung Cancer
    Levy, Antonin
    Guckenberger, Matthias
    Hurkmans, Coen
    Nestle, Ursula
    Belderbos, Jose
    De Ruysscher, Dirk
    Faivre-Finn, Corinne
    Le Pechoux, Cecile
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 92 (04): : 945 - 946
  • [45] Is heterogeneity in stage 3 non-small cell lung cancer obscuring the potential benefits of dose-escalated concurrent chemo-radiotherapy in clinical trials?
    Hudson, Andrew
    Chan, Clara
    Woolf, David
    McWilliam, Alan
    Hiley, Crispin
    O'Connor, James
    Bayman, Neil
    Blackhall, Fiona
    Faivre-Finn, Corinne
    [J]. LUNG CANCER, 2018, 118 : 139 - 147
  • [46] Circulating cell free DNA during definitive chemo-radiotherapy in non-small cell lung cancer patients-Initial observations
    Nygard, Lotte
    Ahlborn, Lise B.
    Persson, Gitte F.
    Chandrananda, Dineika
    Langer, Jonathan W.
    Fischer, Barbara M.
    Langer, Seppo W.
    Gabrielaite, Migle
    Kjaer, Andreas
    Rosenfeld, Nitzan
    Mouliere, Florent
    Ostrup, Olga
    Vogelius, Ivan R.
    Bentzen, Soren M.
    [J]. PLOS ONE, 2020, 15 (04):
  • [47] Concurrent chemo-radiotherapy in locally advanced non-small cell lung cancer (NSCLC): A multicenter randomized phase II study
    Bouillet, T
    Diana, C
    Pailler, M
    Gozy, M
    Labrune, S
    Gervais, R
    Brechot, J
    Breau, J
    Chinet, T
    Morere, J
    [J]. LUNG CANCER, 2005, 49 : S166 - S167
  • [48] Risk Stratification of Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with Chemo-Radiotherapy: An Institutional Analysis
    Sher, Amna
    Medavaram, Sowmini
    Nemesure, Barbara
    Clouston, Sean
    Keresztes, Roger
    [J]. CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 7165 - 7171
  • [49] PROGNOSTIC POTENTIAL OF F-FLURODEOXYGLUCOSE UPTAKE IN NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH RADICAL RADIOTHERAPY OR CONCOMITANT CHEMO-RADIOTHERAPY
    Lin, M. Y.
    Wu, M.
    Brennan, S.
    Campeau, M. P.
    Binns, D.
    Mac Manus, M.
    Solomon, B.
    Hicks, R.
    Ball, D.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S64 - S64
  • [50] Chemo-radiotherapy for stage III unresectable non-small cell lung cancer - long-term results of a prospective study
    Leong, SS
    Fong, KW
    Ong, YK
    Foo, KF
    Ang, P
    Wee, J
    Lee, KM
    Tan, EH
    [J]. RESPIRATORY MEDICINE, 2004, 98 (11) : 1080 - 1086